Immunotherapy for Lung Cancer: The Game-Changing Approach
In the United States, 11% of people battle lung cancer, and 20% die from it. These numbers show we need […]
Immune Checkpoint Inhibitors
Yervoy Opdivo Lung Cancer Treatment Guide
Lung cancer is the top cause of cancer deaths globally, with around 1.8 million people dying each year. This fact
Immunotherapy for Small Cell Lung Cancer: Latest Options
For over thirty years, the fight against small-cell lung cancer (SCLC) hasn’t seen much change. But now, there’s hope with
Immunotherapy Lung Cancer Stage 4: Treatment Guide
Did you know over 15% of people treated with immunotherapy for lung cancer live longer? Immunotherapy has changed cancer care
Neoadjuvant Nivolumab Plus Chemotherapy in Lung Cancer
Adding nivolumab to chemotherapy has been a big step forward in cancer care. It has led to a 24% pathological
Immunotherapy for NSCLC: Latest Treatment Options
Did you know nearly 85% of lung cancers are called non-small cell lung cancer (NSCLC)? This huge number shows the